Exicure, Inc. (XCUR) Year-over-year net earnings per share growth for the last 12 months
The US-based operations and the humanitarian status of RNA therapy minimize geopolitical risks for Exicure, Inc. (XCUR). The business remains independent of GDP cycles, relying instead on grants and clinical milestones. Structural flexibility is maintained through the full outsourcing of production and trials. The quarterly EPS growth history illustrates the depth of drawdowns, where the metric stands at 58.00, helping investors avoid a value trap while searching for the asset's bottom.
Analytical breakdowns and data insights for company Exicure Inc. (XCUR)
- share price and expert price forecast:
- market capitalization details:
- book capitalization indicators:
- business debt structure and liquidity details:
Total Debt to Capital Exicure, Inc.|XCUR - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Exicure, Inc.|XCUR - Company Total Debt Obligations|Debt to Book Value Exicure Inc.|XCUR - Company Long-Term Indebtedness|Company Short-Term Debts Exicure|Quick Liquidity Indicator exicuretx.com
- earnings and valuation multiples indicators:
XCUR - Net Profit|Expected Profit Exicure, Inc.|XCUR - Company Value to Net Income|Forward P/E Multiple Exicure, Inc.|XCUR - Growth-Adjusted P/E Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Exicure Inc.|XCUR - Operating profit before amortization|Net earnings per share (EPS TTM) Exicure|XCUR - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth exicuretx.com|XCUR - Earnings per share growth rate in current year|Expected earnings per share growth for next year Exicure, Inc.
- sales and revenue data:
Analysis of all company metrics:Exicure, XCUR
For Exicure, Inc. (XCUR), whose capitalization depends on the commercialization of the SNA platform amid patent wars, this indicator reflects the efficiency of intellectual property monetization. By calculating the daily rate of change in per-share profit, the quarterly EPS growth trend allows for an assessment of the business's real financial stability, warning investors of the risk of overpaying when purchasing the asset at local peaks of this metric.
Key competitors
TEM: Quarterly EPS earnings growth|Qiagen Corp - Year-over-year earnings per one share growth for the last 12 months|IONS (Ionis Pharmaceuticals) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months RGEN (Repligen)|Quarterly EPS earnings growth RNA|CRSP (CRISPR Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth WGS (GeneDx Holdings Corp.)|RARE: Year-over-year earnings per share growth for the last 12 months|BEAM - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months sarepta.com|TWST: Quarterly EPS earnings growth|TXG - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Intellia|Earnings per share growth in annualized terms for the last twelve months Stoke Therapeutics STOK|Quarterly EPS earnings growth BLFS|Wave Life Sciences - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth MAZE (Maze Therapeutics, Inc.)|Quarterly EPS earnings growth Sionna Pharma SION|Prime Medicine Bio - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months TSHA (Taysha)|QURE: Quarterly EPS earnings growth|MGTX - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months RGNX|SLDB: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months ocugen.com (OCGN)|Year-over-year net earnings per share change for the last twelve months PacBio Corp|Year-over-year earnings per share growth for the last twelve months Benitec Biopharma BNTC|DSGN: Year-over-year earnings per share growth for the last 12 months|RCKT - Year-over-year earnings per share growth for the last twelve months|4dmoleculartherapeutics.com (FDMT) - Year-over-year net earnings per share growth for the last 12 months|lexeotx.com (LXEO) - Year-over-year earnings per share growth for the last twelve months|Korro Bio, Inc (KRRO) - Quarterly EPS earnings growth|EDIT (editasmedicine.com) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months SLN (silence-therapeutics.com)|Year-over-year earnings per share growth for the last twelve months proqr.com (PRQR)|Codexis - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth SGMO (Sangamo Therapeutics)|Quarterly EPS earnings growth nautilus.bio NAUT|Metagenomi Inc. - Quarterly EPS earnings growth|DTIL (Precision BioSciences Inc.) - Year-over-year earnings per share growth for the last 12 months|GBIO: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Boundless Bio, Inc (BOLD)|IMNN (imunon.com) - Quarterly EPS earnings growth|Phio Pharmaceuticals - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Mustang Bio Corp (MBIO)|Quarterly EPS earnings growth TransCode (RNAZ)|Quarterly EPS earnings growth BNGO (bionanogenomics.com)|APDN (Applied DNA Sciences Inc) - Year-over-year net earnings per share trend for the last twelve months|BLUE - Year-over-year earnings per share growth for the last twelve months|ImmunoPrecise Antibodies Ltd. (IPA) - Year-over-year net earnings per share growth for the last 12 months|OMGA (Omega) - Year-over-year net earnings per share growth for the last 12 months|singulargenomics.com (OMIC) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months RGLS|Syros (SYRS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months telesisbio.com (TBIO)|TCON - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth UBX (Unity Biotechnology Inc.)
